The Physiologic and Emotional Effects of Augmented Reality Simulation Versus In Person Simulation - A Noninferiority, Randomized Controlled Trial
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Augmented Reality
- Sponsor
- Stanford University
- Enrollment
- 111
- Locations
- 1
- Primary Endpoint
- Parasympathetic response indexed by RSA
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
This study will evaluate the physiologic and emotional effects of an augmented reality (AR) simulation versus an in-person simulation. This is a single institution, non-inferiority, randomized controlled trial. The target enrollment will be 100 participants in each group for a total of 200 participants. One group will wear an AR headset and participate in an AR medical crisis scenario and the other group will participate in the same scenario with a traditional, mannequin based in situ simulation.
Investigators
Thomas Caruso
Clinical Associate Professor
Stanford University
Eligibility Criteria
Inclusion Criteria
- •Hospital providers, including nurses, physician assistants, physicians, physician trainees, and other healthcare workers at Lucile Packard Children's Hospital (LPCH) and affiliated facilities who communicate with patients daily will be included
Exclusion Criteria
- •Participants with reported severe motion sickness
- •Seizure disorder
- •Currently using chronotropic heart medications, such as β blockers
Outcomes
Primary Outcomes
Parasympathetic response indexed by RSA
Time Frame: Duration of simulation (15-20 minutes)
Measured via respiratory sinus arrhythmia (RSA) in hertz using chest biometric sensors in 30-second epochs.
Secondary Outcomes
- ISO 9241-400(Post-simulation (5 minutes))
- Sytem Usability Scale (SUS)(Post-simulation (5 minutes))
- Simulation Design Scale (SDS)(Post-simulation (5-10 minutes))
- Learning effectiveness(5 months-post simulation (5 minutes))